Drug Detection Panel, Meconium, Qualitative

Use

This test is used to detect and document fetal drug exposure during approximately the last trimester of a full-term pregnancy. It aids in identifying maternal drug use by examining the drug deposition in meconium. The test results may provide insights into potential maternal drug use patterns, though the exact frequency of drug usage by the mother cannot be determined. The detection in meconium helps in understanding drug exposure conditions that the fetus might have experienced during gestation. However, it's important to note that this analysis is intended for clinical purposes only and not valid for forensic use.